{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T05:07:21Z","timestamp":1739596041841,"version":"3.37.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00520-025-09209-y","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T07:29:31Z","timestamp":1738394971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Red light therapy for patients with chemotherapy-induced alopecia"],"prefix":"10.1007","volume":"33","author":[{"given":"Lucy","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layna","family":"Mager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Hordinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Dulmage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"issue":"5","key":"9209_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00520-023-07743-1","volume":"31","author":"J Lodewijckx","year":"2023","unstructured":"Lodewijckx J, Robijns J, Claes M, Pierson M, Lenaerts M, Mebis J (2023) The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial). Support Care Cancer 31(5):269. https:\/\/doi.org\/10.1007\/s00520-023-07743-1","journal-title":"Support Care Cancer"},{"issue":"1","key":"9209_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1186\/s13063-023-07823-x","volume":"24","author":"CX Wu","year":"2023","unstructured":"Wu CX, Li CH, Shiao YH, Cheng HY, Wu TH, Lee CH, Chang ZY, Yeh YC (2023) The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial. Trials 24(1):789. https:\/\/doi.org\/10.1186\/s13063-023-07823-x","journal-title":"Trials"},{"key":"9209_CR3","unstructured":"https:\/\/www.plasticsurgery.org\/news\/blog\/what-is-led-light-therapy-and-what-are-the-benefits#:~:text=Red%20light%20is%20used%20to,collagen%20proteins%20are%20then%20stimulated"},{"issue":"4","key":"9209_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4103\/JCAS.JCAS_218_20","volume":"14","author":"JK Pillai","year":"2021","unstructured":"Pillai JK, Mysore V (2021) Role of low-level light therapy (LLLT) in androgenetic alopecia. J Cutan Aesthet Surg 14(4):385\u2013391","journal-title":"J Cutan Aesthet Surg"},{"issue":"6","key":"9209_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10103-019-02723-6","volume":"34","author":"KH Liu","year":"2019","unstructured":"Liu KH, Liu D, Chen YT, Chin SY (2019) Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials. Lasers Med Sci 34(6):1063\u20131069","journal-title":"Lasers Med Sci"},{"issue":"3","key":"9209_CR6","doi-asserted-by":"publisher","first-page":"e14940","DOI":"10.1111\/dth.14940","volume":"34","author":"M Amer","year":"2021","unstructured":"Amer M, Nassar A, Attallah H, Amer A (2021) Results of low-level laser therapy in the treatment of hair growth: an Egyptian experience. Dermatol Ther 34(3):e14940","journal-title":"Dermatol Ther"},{"issue":"5","key":"9209_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4103\/ijdvl.IJDVL_1156_16","volume":"84","author":"G Faghihi","year":"2018","unstructured":"Faghihi G, Mozafarpoor S, Asilian A, Mokhtari F, Esfahani AA, Bafandeh B, Nouraei S, Nilforoushzadeh MA, Hosseini SM (2018) The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia. Indian J Dermatol Venereol Leprol 84(5):547\u2013553","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"9209_CR8","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s00403-023-02660-z","volume":"315","author":"A Minta","year":"2023","unstructured":"Minta A, Park C, Rose L et al (2023) Retrospective review of oral and topical minoxidil for cancer treatment-induced hair loss. Arch Dermatol Res 315:2613\u20132615. https:\/\/doi.org\/10.1007\/s00403-023-02660-z","journal-title":"Arch Dermatol Res"},{"key":"9209_CR9","unstructured":"Rossi A (n.d.) A study of platelet-rich plasma (PRP) treatment for hair loss after cancer therapy in women with breast cancer. NCT04459650. \nhttps:\/\/www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2020-05259. Accessed 7 Apr 2024"},{"key":"9209_CR10","unstructured":"National Cancer Institute (U.S.) (n.d.) A study of platelet-rich plasma (PRP) treatment for hair loss after cancer therapy in women with breast cancer. NCT04459650. \nhttps:\/\/www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2020-05259. Accessed 7 Apr 2024"},{"key":"9209_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000528518","volume":"9","author":"D Chopra","year":"2023","unstructured":"Chopra D, Balukoff N, Motosoko C (2023) Effect of skin type on efficacy of laser treatment for androgenetic alopecia: a review of the literature. Skin Appendage Disord 9:317\u2013324. https:\/\/doi.org\/10.1159\/000528518","journal-title":"Skin Appendage Disord"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09209-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T05:40:53Z","timestamp":1739511653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09209-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["9209"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09209-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Dr.\u00a0Dulmage\u00a0is a consultant for\u00a0Novocure\u00a0and serves on the Data Safety and Management Board of\u00a0Hoth\u00a0Therapeutics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"137"}}